Diabetes is a growing global health problem, affecting an increasing number of people every year. In the United States, the prevalence of diabetes and prediabetes is alarmingly high, particularly among adults over 65. These conditions increase the risk of heart problems, kidney failure and visual impairment, creating a significant public health burden.
When someone is hospitalized with high blood sugar, it can worsen their health problems. Yet doctors cannot determine the previous trend in sugar levels solely from that moment. The HbA1c test offers a more comprehensive view, reflecting average blood sugar levels over several weeks.
By calculating the hyperglycemic stress ratio from this data, healthcare professionals can assess the risk of cardiac complications, even in people without diabetes.
Prediabetes, a critical phase, indicates early metabolic dysfunction that can progress to type 2 diabetes. People with prediabetes often have a variety of metabolic disorders, such as dysglycemia, dyslipidemia, hypertension and obesity, which favor the development of diabetes and its complications.
In addition, stress factors such as financial worries, strained family relationships and loneliness can aggravate the situation.
Early management of prediabetes is essential to prevent or delay the onset of type 2 diabetes and its complications. Interventions must therefore address unhealthy lifestyles, including promoting a balanced diet, weight loss where necessary, regular physical activity and stress management.
Regular medical follow-up is also crucial to monitor blood sugar levels and adjust treatment plans as necessary.
In conclusion, awareness, early detection and the adoption of healthy lifestyles are essential to promote metabolic health and prevent chronic diseases such as type 2 diabetes.
Early management of prediabetes can help prevent or delay the development of type 2 diabetes and reduce the risk of associated complications.
Learn more about Pep2Dia to maintain a healthy glycemia!
Sources:
Ding L, Zhang H, Dai C, Zhang A, Yu F, Mi L, Qi Y, Tang M.
Cardiovasc Diabetol. 2024 Feb 28;23(1):84. doi: 10.1186/s12933-024-02172-8.
Diagnosis and Management of Prediabetes: A Review.
Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S.
JAMA. 2023 Apr 11;329(14):1206-1216. doi: 10.1001/jama.2023.4063.
Wallace DD, Lytle LA, Albrecht S, Barrington C.
J Lat Psychol. 2021 Aug;9(3):204-216. doi: 10.1037/lat0000168.
Oxidative stress and inflammatory markers in prediabetes and diabetes.
Luc K, Schramm-Luc A, Guzik TJ, Mikolajczyk TP.
J Physiol Pharmacol. 2019 Dec;70(6). doi: 10.26402/jpp.2019.6.01.
Health risks and interventions in prediabetes: A review.
Mahat RK, Singh N, Arora M, Rathore V.
Diabetes Metab Syndr. 2019 Jul-Aug;13(4):2803-2811. doi: 10.1016/j.dsx.2019.07.041.
Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM.
Cell Metab. 2018 Jun 5;27(6):1212-1221.e3. doi: 10.1016/j.cmet.2018.04.010.